| 000 | 01744 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511175826.0 | ||
| 264 | 0 | _c19920330 | |
| 008 | 199203s 0 0 eng d | ||
| 022 | _a0892-6638 | ||
| 024 | 7 |
_a10.1096/fasebj.6.2.1311272 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPuga, A | |
| 245 | 0 | 0 |
_aTranscriptional derepression of the murine Cyp1a-1 gene by mevinolin. _h[electronic resource] |
| 260 |
_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cJan 1992 |
||
| 300 |
_a777-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Nucleus _xphysiology |
| 650 | 0 | 4 |
_aCycloheximide _xpharmacology |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xbiosynthesis |
| 650 | 0 | 4 | _aDNA Probes |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aEnzyme Repression |
| 650 | 0 | 4 | _aHydroxymethylglutaryl-CoA Reductase Inhibitors |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLiver Neoplasms, Experimental |
| 650 | 0 | 4 |
_aLovastatin _xpharmacology |
| 650 | 0 | 4 |
_aMevalonic Acid _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 |
_aPolychlorinated Dibenzodioxins _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aReceptors, Aryl Hydrocarbon |
| 650 | 0 | 4 |
_aReceptors, Drug _xmetabolism |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aRaychaudhuri, B | |
| 700 | 1 | _aNebert, D W | |
| 773 | 0 |
_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 6 _gno. 2 _gp. 777-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1096/fasebj.6.2.1311272 _zAvailable from publisher's website |
| 999 |
_c1317795 _d1317795 |
||